Cleared Traditional

K163215 - AnemoCheck

K163215 is an FDA 510(k) clearance for AnemoCheck, manufactured by Sanguina, LLC. The device is a Class 2 Hematology device with product code KHG cleared through the Traditional 510(k) pathway after a 301-day FDA review.

K163215 · Sanguina, LLC · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2017
Decision
301d
Days
Class 2
Risk

K163215 is an FDA 510(k) clearance for the AnemoCheck. Classified as Whole Blood Hemoglobin Determination (product code KHG), Class II - Special Controls.

Submitted by Sanguina, LLC (Atlanta, US). The FDA issued a Cleared decision on September 13, 2017 after a review of 301 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.7500 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Hematology review framework, consistent with the majority of Class II 510(k) submissions.

View all Sanguina, LLC devices

FDA 510(k) Submission Details - K163215

510(k) Number K163215 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 16, 2016
Decision Date September 13, 2017
Days to Decision 301 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
188d slower than avg
Panel avg: 113d · This submission: 301d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

KHG Device Classification - Class 2, Special Controls

Product Code KHG Whole Blood Hemoglobin Determination
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.7500
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Consultant

Cambria Regulatory Consulting, Inc.
CATHRYN N CAMBRIA

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - KHG Whole Blood Hemoglobin Determination

All 30
Devices cleared under the same product code (KHG) and FDA review panel - the closest regulatory comparables to K163215.
AnemoCheck Home
K221508 · Sanguina, Inc. · Sep 2023
ANEMIAPRO SELF-SCREENER
K042379 · Biosafe Laboratories, Inc. · Dec 2004
CARESIDE HEMOGLOBIN
K001462 · Careside, Inc. · Aug 2000
HEMOSITE TEST SYSTEM
K994073 · Gds Technology, LLC · Jan 2000
HEMOSITE TEST SYSTEM
K973649 · Gds Technology, LLC · Aug 1998
ABBOTT VISION HEMOGLOBIN (MODIFICATION)
K953221 · Abbott Laboratories · Sep 1995